Skip to content
  • Brazil
  • Canada
  • Europe
  • India
  • Italy
  • Japan
  • Korea
  • Latam
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
  • Country/Region
  • No block ID is set

  • Clinic Portal
    • +0034963905310
  • Request Information
  • +34 96 390 53 10
  • Part of brands: |
InternationalInternational
  • Country/Region
  • Part of brands: |
  • Patient Journey
    • Before Pregnancy
    • IVF Process
    • Healthy pregnancy
    • After birth
  • Reproductive Health
    • Specialists
      • ERA
      • ERA insight Hub
      • ALICE
      • EMMA
      • EndomeTRIO
      • Infertility Panels
      • EMBRACE
      • PGT-A
      • PGT-A Plus
      • PGT-M
      • PGT-SR
      • CGT
      • NACE
      • Zenit
      • POC Portfolio
      • SAT
      • Newborn Screening
  • Diagnostics
  • About us
    • Igenomix Research
    • About Igenomix
    • Igenomix Worldwide
  • Academy
  • Blog
Genomics Precision Diagnostic > Hematology Precision Panel > Hereditary Thrombophilias Precision Panel

Hereditary Thrombophilias Precision Panel

Hereditary Thrombophilias are states of hypercoagulability that increase the risk of patients to develop clots, venous thrombosis and arterial thrombosis. Out of these, venous thrombosis and pulmonary embolism carry the highest risk of morbidity and mortality.
Overview
Indication
Clinical Utility
Genes & Diseases
Methodology
References

Overview

  • Hereditary Thrombophilias are states of hypercoagulability that increase the risk of patients to develop clots, venous thrombosis and arterial thrombosis. Out of these, venous thrombosis and pulmonary embolism carry the highest risk of morbidity and mortality. Some hereditary thrombophilias include Factor V Leiden, Prothrombin 20210A, Protein C deficiency, Protein S deficiency and Antithrombin deficiency. Out of these, Factor V Leiden is the most common form of inherited thrombophilia. Thrombophilias may have an autosomal dominant, autosomal recessive or X-linked inheritance. Association of inherited thrombophilias with pregnancy increases the risk of thromboembolic events and it may be related to other complications such as preeclampsia, recurrent miscarriages, early detachment of the placenta and prematurity.   

  • The Igenomix Hereditary Thrombophilias Precision Panel can be used to make an accurate and directed diagnosis as well as a differential diagnosis of recurrent thrombosis ultimately leading to a better management and prognosis of the disease. It provides a comprehensive analysis of the genes involved in this disease using next-generation sequencing (NGS) to fully understand the spectrum of relevant genes involved.  

Indication

  • The Igenomix Hereditary Thrombophilias Precision Panel is indicated for those patients with a clinical suspicion or diagnosis with or without the following manifestations: 
    • History of recurrent thromboembolism 
    • Thrombosis at a young age 
    • Family history of thrombosis 
    • Thrombosis in unusual sites 

Clinical Utility

The clinical utility of this panel is: 

  • The genetic and molecular confirmation for an accurate clinical diagnosis of a symptomatic patient.  
  • Early initiation of treatment with a multidisciplinary team in the form of medical care with anticoagulants and management of bleeding. 
  • Risk assessment and genetic counselling of asymptomatic family members according to the mode of inheritance. 
  • Improvement of delineation of genotype-phenotype correlation. 
  • Identification of causative genes of hereditary thrombophilias given the high degree of heterogeneity with various clinical presentations and prognoses.

Genes & Diseases

Methodology

References

See scientific referrals

Dautaj, A., Krasi, G., Bushati, V., Precone, V., Gheza, M., Fioretti, F., Sartori, M., Costantini, A., Benedetti, S., & Bertelli, M. (2019). Hereditary thrombophilia. Acta bio-medica : Atenei Parmensis, 90(10-S), 44–46. https://doi.org/10.23750/abm.v90i10-S.8758 

Trasca, L. F., Patrascu, N., Bruja, R., Munteanu, O., Cirstoiu, M., & Vinereanu, D. (2019). Therapeutic Implications of Inherited Thrombophilia in Pregnancy. American journal of therapeutics, 26(3), e364–e374. https://doi.org/10.1097/MJT.0000000000000985 

Campello, E., Spiezia, L., & Simioni, P. (2016). Diagnosis and management of factor V Leiden. Expert review of hematology, 9(12), 1139–1149. https://doi.org/10.1080/17474086.2016.1249364 

Campello, E., Spiezia, L., Adamo, A., & Simioni, P. (2019). Thrombophilia, risk factors and prevention. Expert review of hematology, 12(3), 147–158. https://doi.org/10.1080/17474086.2019.1583555 

Montagnana, M., Lippi, G., & Danese, E. (2017). An Overview of Thrombophilia and Associated Laboratory Testing. Methods in molecular biology (Clifton, N.J.), 1646, 113–135. https://doi.org/10.1007/978-1-4939-7196-1_9 

Rosendaal, F. (1999). Venous thrombosis: a multicausal disease. The Lancet, 353(9159), 1167-1173. doi: 10.1016/s0140-6736(98)10266-0 

descargar

Detail description

Download

Request Information

WE GUIDE YOU

Fertility
Inherited diseases prevention
Healthy pregnancy

To see the accreditation certificate, associated technical annex and list of accredited tests, click on this link.

OUR SERVICES

Genetic testing solutions
For patients
How to send a sample?
User manual

ABOUT US

About Igenomix
Contact
Quality
Complaints
Work with us
Terms and conditions

FOLLOW IGENOMIX

  + 96 390 53 10
  Write us
  • Brazil
  • Canada
  • Europe
  • India
  • Italy
  • Japan
  • Korea
  • Latam
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
Country/Region

[2024] © Igenomix Privacy Page Quality policy Legal note Cookies policy

Request Information


  • Patient Journey
    • Before Pregnancy
    • IVF Process
    • Healthy pregnancy
    • After birth
  • Reproductive Health
    • Specialists
      • ERA
      • ERA insight Hub
      • ALICE
      • EMMA
      • EndomeTRIO
      • Infertility Panels
      • EMBRACE
      • PGT-A
      • PGT-A Plus
      • PGT-M
      • PGT-SR
      • CGT
      • NACE
      • Zenit
      • POC Portfolio
      • SAT
      • Newborn Screening
  • Diagnostics
  • About us
    • Igenomix Research
    • About Igenomix
    • Igenomix Worldwide
  • Academy
  • Blog
  • Country/Region
  • +34 96 390 53 10
  • Clinic Portal
  • Request Information